Autoimmunity Reviews

Article	Citations
Editorial Board	212
Editorial Board	163
Comment on “Meta-analysis of meteorological conditions and rheumatoid arthritis”	135
MTHFR polymorphisms in autoimmune diseases: Mechanistic and clinical perspectives	123
The Trm-Treg Axis as a tissue-encoded immune checkpoint in chronic inflammation and autoimmunity	123
The role of musculoskeletal ultrasound in difficult-to-treat RA: Insights from a systematic literature review	112
The BAFF/APRIL system at the crossroads of B cell memory and autoimmune relapse: Implication into the therapeutic strategies	110
Epidemiological patterns and in-hospital mortality in ANCA-associated vasculitis: Insights from Spain's National Health Data (2016–2022)	106
Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist's perspective	105
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence	98
Endometriosis and autoimmunity	98
Characteristics and risk factors for infection in patients with ANCA-associated vasculitis: A systematic review and meta-analysis	95
T lymphocyte plasticity in chronic inflammatory diseases: The emerging role of the Ikaros family as a key Th17-Treg switch	94
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders	86
Autoantibody internalization in myositis skeletal muscle: Emerging evidence, mechanistic insights, and therapeutic relevance	85
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis	80
To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debate	72
Metabolic traits of T cells and the implications in autoimmune diseases	70
Psychiatric manifestations of autoimmune encephalitis	69
Can anticoagulation be withdrawn in APS patients after aPL negativization?	69
Editorial Board	69
Corrigendum to “Proportion of circulating T follicular helper cells in peripheral blood of systemic lupus erythematosus patients: A systematic review and meta-analysis” [Autoimmunity Reviews Volume 24	64
WITHDRAWN: Global incidence trends of autoimmune diseases from 1990 to 2021 and projections to 2050: A systemic analysis of the global burden of disease study 2021	64
Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature	63
The immune system in Hashimoto's thyroiditis: Updating the current state of knowledge on potential therapies and animal model construction	61

Advances in precision medicine in imaging and therapeutic strategies for psoriatic disease	61
Homocysteine as a trigger and potential therapeutic target for autoimmune diseases	61
Human abdominal aortic aneurysm (AAA): Evidence for an autoimmune antigen-driven disease.	59
Autoimmune pre-disease	59
Understanding the effects of Janus kinase inhibitors on the cardiovascular system in comparison to main biological DMARDs in rheumatoid arthritis	58
STING-inflammasome axis in autoimmune diseases and inflammation-related disease	57
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy	56
Dysregulation of helper, regulatory, and follicular CD4+ T cells in primary antiphospholipid syndrome: Immunopathology and implications for targeted immunomodulatory therapy	55
Fecal microbiota transplantation in autoimmune diseases – An extensive paper on a pathogenetic therapy	54
Autoimmunity, diet and autophagy	52
Rebalancing redox homeostasis: A pivotal regulator of the cGAS-STING pathway in autoimmune diseases	51
Idiopathic pericarditis in 2025: Advances in diagnosis and therapeutic strategies	51
Conceiving complexity: Biological mechanisms underpinning the lasting effect of pregnancy on multiple sclerosis outcomes	51
Seronegative autoimmune diseases: A challenging diagnosis	49
Editorial Board	49
Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium	48
Research progress on estrogen and estrogen receptors in the occurrence and progression of autoimmune thyroid diseases	47
Editorial Board	47
Systematic evaluation of the associations between schizophrenia and autoimmune diseases: An umbrella review	45
Indian Rheumatology Association guidelines for the management of ANCA associated vasculitis	45
Refining search and keyword strategies in autoimmune ear disease bibliometric studies	45
Adipose failure through adipocyte overload and autoimmunity	45
Chinese recommendations for the diagnosis and management of non-radiographic axial spondyloarthritis	44
VEXAS syndrome in adults: A narrative review of genomic pathogenesis, multisystem phenotypes, diagnostic algorithms, and emerging therapeutic strategies	43
The genealogy, methodology, similarities and differences of immune reconstitution therapies for multiple sclerosis and neuromyelitis optica	42
Cerebral vasculitis as a clinical manifestation of neurosarcoidosis: A scoping review	42
IFN-γ: An overlooked cytokine in dermatomyositis with anti-MDA5 antibodies	42
SpA plus IBD or IBD plus SpA: Does commutative property apply?	41
Predicting autoimmune diseases: A comprehensive review of classic biomarkers and advances in artificial intelligence	41
Inclusion body myositis: Correcting impaired mitochondrial and lysosomal autophagy as a potential therapeutic strategy	41
Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: Opportunities and challenges	41
Complex relationships of type 2 and type 1 symptoms across various systemic autoimmune diseases.	40
Effects of cytotoxic T-lymphocyte-associated protein 4 compared to TNF inhibitors on lipid profile: Results from an observational multicentre rheumatoid arthritis cohort	40
Controversies in in rheumatology and autoimmunity: Is CORA meeting a good educational tool to increase the scientific knowledge?	40
Are breast cancer patients diagnosed after systemic sclerosis showing different pathological characteristics?	40
Specialized pro-resolving mediators and autoimmunity: Recent insights and future perspectives	40
Regulatory mechanisms and targeted therapeutic strategies of glycolytic metabolism in rheumatoid arthritis	39
Fibromyalgia: Are we using the biopsychosocial model?	38
Chronic inflammation in Long COVID relationship to autoimmune diseases	37
LAG-3 in (auto)immunity and cancer - Emphasising its role in antigen presenting cells	37
Mechanisms of environmental risk factors for autoimmune diseases	37
Factors associated with incident cardiovascular disease in patients with rheumatoid arthritis: A scoping review	37
Development of an algorithm for IgG4-related disease management	36
The role of mitochondrial dysfunction in kidney injury and disease	36
Phage ImmunoPrecipitation sequencing (PhIP-Seq) in autoimmunity research: From high-resolution epitope mapping to multi-omics integration	35
Combined immunosuppressive therapy in systemic sclerosis-associated interstitial lung disease: Phenotypes matter	35
Tumor necrosis factor-α inhibitor-related autoimmune disorders	35
Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines	35
Will a hyperactive classical complement pathway exacerbate autoimmune diseases?	34
Antibiotic-induced gut dysbiosis and autoimmune disease: A systematic review of preclinical studies	34

Editorial Board	34
Editorial Board	34
Are IF-ANA the guiding light for SLE classification in the real-world setting?	33
Editorial Board	33
Twenty shades of the mosaic of autoimmunity	32
Dysfunction of the glymphatic system and sleep disturbance in rheumatoid arthritis and musculoskeletal pain: A gap related to pain becoming chronic	32
Mesenchymal stem cell in immunomodulation of dendritic cells: Implications for inflammatory bowel disease therapy	32
Differences in clinical phenotype, laboratory, and imaging manifestations between AQP4 IgG positive and AQP4 MOG IgG double negative NMOSD: How to correctly diagnose the two	32
Clinical characteristics and cancer risk of anti-OJ antisynthetase syndrome: A cohort comparative study and a systematic literature review	31
Coffee consumption and risk of multiple sclerosis: A systematic review and meta-analysis	31
Fatty acid oxidation and inflammatory bowel disease: Highlighting the roles of pathogenesis and treatment	30
Proportion of circulating T follicular helper cells in peripheral blood of systemic lupus erythematosus patients: A systematic review and meta-analysis	30
Alarmins in autoimmune diseases	30
Editorial Board	30
A machine learning analysis to evaluate the outcome measures in inflammatory myopathies	30
The rituximab paradox in rheumatoid arthritis: Re-evaluating B-cell depletion depth and the synovial microenvironment	30
Impact of GLP-1 analogues on immune-mediated inflammatory diseases: A systematic review	30
Predicting the course: Real-world trajectories toward minimal disease activity in psoriatic arthritis	30
Global burden due to modifiable risk factors for autoimmune diseases, 1990–2021: Temporal trends and socio-demographic inequalities	30
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechan	30
Angiogenic imbalance and endothelial dysfunction in the placenta in antiphospholipid syndrome	29
Neuroimaging in thyroid eye disease: A systematic review	29
Anti-CD52 therapy of rheumatic diseases: Revisited in the era of immune reset	29
Low-dose intravenous immunoglobulin (IVIg) in different immune-mediated conditions	29
Cutting edge confusion about cut-off settings in autoimmune diagnostics	29
In Memoriam: Pierre Youinou	29
The impact of pregnancy on future health in Rheumatoid Arthritis: A systematic review of the literature	29
Mucosal immunity and rheumatoid arthritis: An update on mechanisms and therapeutic potential	28
From autoantibody test results to decision making: Incorporating likelihood ratios within medical practice	28
IL-33 in Spondyloarthritis, the missing key	28
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) in 2023	28
Diagnostic approach in giant cell arteritis	27
Prevalence of immune-mediated inner ear disease in non-segmental vitiligo: A cross-sectional study	27
Editorial Board	27
Development of systemic lupus erythematosus in patients with immune thrombocytopenic purpura: A systematic meta-analysis	26
Differentially expressed genes in systemic sclerosis: Towards predictive medicine with new molecular tools for clinicians	26
Extending the discussion: Cannabis based therapies in inflammatory bowel disease a letter to the editor	25
Subcutaneous tissue involvement in idiopathic inflammatory myopathies: Systematic literature review including three new cases and hypothetical mechanisms	25
Imaging the hidden player: Choroid plexus enlargement in multiple sclerosis	25
Potential immunological and genetic markers associated with lupus nephritis: From pathogenicity to therapeutic drug target	25
Risk factors associated with thrombocytopenia in systemic lupus erythematosus: A systematic review and meta-analysis	24
Genetic and genomic associations in antiphospholipid syndrome: A systematic review	24
Serum calprotectin is a marker of disease activity in Giant cell arteritis	24
Burden of inflammatory bowel disease among elderly, 1990–2019: A systematic analysis based on the global burden of disease study 2019	24
Macrophages in Lupus Nephritis: Exploring a potential new therapeutic avenue	23
Prevention of rheumatoid arthritis: A systematic literature review of preventive strategies in at-risk individuals	23
JAK inhibitors and systemic sclerosis: A systematic review of the literature	23
Gut microbiota in rheumatoid arthritis: Mechanistic insights, clinical biomarkers, and translational perspectives	23
Treatment of acute exacerbation in interstitial lung disease secondary to autoimmune rheumatic diseases: More questions than answers	23
Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data	23
Persistence of antiphospholipid antibodies over time and its association with recurrence of clinical manifestations: A longitudinal study from a single centre	23
Don't mix apples and oranges. Reply to Azoulay et al.	22
Structural cell heterogeneity underlies the differential contribution of IL-17A, IL-17F and IL-23 to joint versus skin chronic inflammation	22
Rapid radiographic progression in rheumatoid arthritis: Definition, prediction and treatment	22
Is it time for treat-to-target in antiphospholipid syndrome?	22
Editorial Board	22
Inhibitors of Bruton's tyrosine kinase as emerging therapeutic strategy in autoimmune diseases	22
Persistent aortic inflammation in patients with giant cell arteritis	22
From inflammation to renal fibrosis: A one-way road in autoimmunity?	22
Cerebral iron accumulation in multiple sclerosis: Pathophysiology and therapeutic implications	22
Editorial Board	22
Ferritinophagy in inflammatory and autoimmune diseases: Mechanistic insights and therapeutic potentials	22
Editorial Board	21
The emerging concept of ANCA-associated vasculitis related to inborn errors of immunity	21
Identifying subsets of patients with undifferentiated connective tissue disease: Results from a prospective, real-world experience using particle-based multi-analyte technology	21
Scleroderma cardiac crisis: A-life-threatening but reversible complication of systemic sclerosis	21
Editorial Board	21
IgA vasculitis sibling clustering: From HLA-DRB1 genetic burden to nephritis risk stratification	21
Research advances on targeted-Treg therapies on immune-mediated kidney diseases	21
Insights into new-onset autoimmune diseases after COVID-19 vaccination	20
The threat of triple M and autoimmune overlap syndromes with immune checkpoint inhibitors - A series of case reports	20
The assessment and management of bone health in pediatric-onset rheumatological diseases from early age to adulthood: A critical overview	20
The role of bDMARDs in idiopathic inflammatory myopathies: A systematic literature review	20
Glomerulonephritis and inflammatory bowel disease: A tale of gut-kidney axis dysfunction	20
Anti-glomerular basement membrane vasculitis	20
IgG4 in the gut: Gastrointestinal IgG4-related disease or a new subtype of inflammatory bowel disease	20
Regulated cell death in systemic lupus erythematosus: Key pathways and targeted therapies	20
Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis	20
Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series	20
Systemic lupus erythematosus in critical care: A systematic review of ICU outcomes and management	20

Heavy and trace metals toxicity implications in the breakdown of cellular homeostasis: A risk factor for rheumatoid arthritis pathogenesis	20
Autoantibodies against tyrosyl-tRNA synthetase (anti-Ha antibodies)	20
Intermittent fasting: A promising dietary intervention for autoimmune diseases	20
Prevalence and clinical correlates of infection in idiopathic inflammatory myopathies: A systematic review and meta-analysis of 14,548 patients	19
Corrigendum to ‘Dynamic profiling in inflammatory Bowel disease: A manifesto for personalized care’ [Autoimmunity Reviews 25 (2026) 104068]	19
Emerging roles of mechanically activated ion channels in autoimmune disease	19
Editorial Board	19
Clinical features, pathogenesis, and treatment of inflammatory bowel disease-associated spondyloarthritis	19
Janus kinase inhibitors for psoriatic arthritis: Evidence from a systematic review and network meta-analysis	19
Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus – A proposal from an expert panel	19
Outcomes of ICU patients treated with intravenous immunoglobulin for sepsis or autoimmune diseases	19
The interferon in idiopathic inflammatory myopathies: Different signatures and new therapeutic perspectives. A literature review	19
Involvement of aquaporin 5 in Sjögren’s syndrome	19
Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)	19
Prevention of rheumatoid arthritis using a familial predictive medicine approach	19
Advancing understanding of autoimmune disease-related interstitial lung disease (AD-ILD): A global perspective on research focus and future directions	19